federal_register: 2010-22039

All Federal Register documents (rules, proposed rules, notices, presidential documents) from 1994 to present. Nearly 1M documents with full-text search.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

document_number title type abstract publication_date pub_year pub_month html_url pdf_url agency_names agency_ids excerpts regulation_id_numbers
2010-22039 Implantation or Injectable Dosage Form New Animal Drugs; Florfenicol and Flunixin Rule The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a supplemental new animal drug application (NADA) filed by Intervet, Inc. The supplemental NADA adds Mycoplasma bovis to the bovine respiratory disease (BRD) pathogens for which use of an injectable solution containing florfenicol and flunixin meglumine is an approved treatment. 2010-09-03 2010 9 https://www.federalregister.gov/documents/2010/09/03/2010-22039/implantation-or-injectable-dosage-form-new-animal-drugs-florfenicol-and-flunixin https://www.govinfo.gov/content/pkg/FR-2010-09-03/pdf/2010-22039.pdf Health and Human Services Department; Food and Drug Administration 221,199 The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a supplemental new animal drug application (NADA) filed by Intervet, Inc. The supplemental NADA adds Mycoplasma bovis to the bovine respiratory...  

Links from other tables